GI
PTLA

GLG Inc’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

GLG Inc’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$795K Buy
+30,860
New +$750K 0.02% 545

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

GLG Inc's PTLA Position: Q4 2013 in Review

GLG Inc opened a new position in Portola Pharmaceuticals, Inc. (PTLA) in Q4 2013: 30,860 shares worth $795K. The stake represents 0.02% of the portfolio and ranks #545 among its holdings.

92 funds tracked by Wall St. Rank hold PTLA as of Q4 2013.

  • GLG Inc held 30,860 shares of Portola Pharmaceuticals, Inc. worth $795K as of Q4 2013.
  • Portola Pharmaceuticals, Inc. was a new GLG Inc position in Q4 2013.
  • Portola Pharmaceuticals, Inc. made up 0.02% of GLG Inc's portfolio in Q4 2013, its #545 holding.
  • 92 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.